GB9303518D0 - Combinations of retroviral inhibitors - Google Patents

Combinations of retroviral inhibitors

Info

Publication number
GB9303518D0
GB9303518D0 GB939303518A GB9303518A GB9303518D0 GB 9303518 D0 GB9303518 D0 GB 9303518D0 GB 939303518 A GB939303518 A GB 939303518A GB 9303518 A GB9303518 A GB 9303518A GB 9303518 D0 GB9303518 D0 GB 9303518D0
Authority
GB
United Kingdom
Prior art keywords
combinations
retroviral inhibitors
retroviral
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939303518A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Priority to GB939303518A priority Critical patent/GB9303518D0/en
Publication of GB9303518D0 publication Critical patent/GB9303518D0/en
Priority to HU9502451A priority patent/HUT72493A/hu
Priority to CN94191250A priority patent/CN1118142A/zh
Priority to JP6518971A priority patent/JPH08509469A/ja
Priority to US08/492,089 priority patent/US5939430A/en
Priority to CA002155129A priority patent/CA2155129C/en
Priority to AU60918/94A priority patent/AU679497B2/en
Priority to NZ261740A priority patent/NZ261740A/en
Priority to EP94907268A priority patent/EP0684836A1/en
Priority to PCT/US1994/000710 priority patent/WO1994019008A1/en
Priority to KR1019950703531A priority patent/KR100293299B1/ko
Priority to ZA941036A priority patent/ZA941036B/xx
Priority to IL10869694A priority patent/IL108696A/en
Priority to MXPA94001311A priority patent/MXPA94001311A/es
Priority to NO953272A priority patent/NO307738B1/no
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB939303518A 1993-02-22 1993-02-22 Combinations of retroviral inhibitors Pending GB9303518D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GB939303518A GB9303518D0 (en) 1993-02-22 1993-02-22 Combinations of retroviral inhibitors
KR1019950703531A KR100293299B1 (ko) 1993-02-22 1994-01-18 레트로비루스억제제배합물
AU60918/94A AU679497B2 (en) 1993-02-22 1994-01-18 Combinations of retroviral inhibitors
EP94907268A EP0684836A1 (en) 1993-02-22 1994-01-18 Combinations of retroviral inhibitors
JP6518971A JPH08509469A (ja) 1993-02-22 1994-01-18 レトロウイルス抑制剤の組合わせ
US08/492,089 US5939430A (en) 1993-02-22 1994-01-18 Combinations of retroviral inhibitors
CA002155129A CA2155129C (en) 1993-02-22 1994-01-18 Combinations of retroviral inhibitors
HU9502451A HUT72493A (en) 1993-02-22 1994-01-18 Combinations of retroviral inhibitors
NZ261740A NZ261740A (en) 1993-02-22 1994-01-18 Pharmaceutical compositions for treating hiv
CN94191250A CN1118142A (zh) 1993-02-22 1994-01-18 逆转录病毒抑制剂组合物
PCT/US1994/000710 WO1994019008A1 (en) 1993-02-22 1994-01-18 Combinations of retroviral inhibitors
ZA941036A ZA941036B (en) 1993-02-22 1994-02-15 Combinations of retroviral inhibitors
IL10869694A IL108696A (en) 1993-02-22 1994-02-17 Pharmaceutical preparations containing castanospermine and dipeptide for the treatment of retroviral infections
MXPA94001311A MXPA94001311A (es) 1993-02-22 1994-02-21 Combinaciones de inhibidores retrovirales.
NO953272A NO307738B1 (no) 1993-02-22 1995-08-21 Farmasøytisk preparat av retrovirale inhibitorer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939303518A GB9303518D0 (en) 1993-02-22 1993-02-22 Combinations of retroviral inhibitors

Publications (1)

Publication Number Publication Date
GB9303518D0 true GB9303518D0 (en) 1993-04-07

Family

ID=10730826

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939303518A Pending GB9303518D0 (en) 1993-02-22 1993-02-22 Combinations of retroviral inhibitors

Country Status (14)

Country Link
EP (1) EP0684836A1 (no)
JP (1) JPH08509469A (no)
KR (1) KR100293299B1 (no)
CN (1) CN1118142A (no)
AU (1) AU679497B2 (no)
CA (1) CA2155129C (no)
GB (1) GB9303518D0 (no)
HU (1) HUT72493A (no)
IL (1) IL108696A (no)
MX (1) MXPA94001311A (no)
NO (1) NO307738B1 (no)
NZ (1) NZ261740A (no)
WO (1) WO1994019008A1 (no)
ZA (1) ZA941036B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2889014A1 (fr) 2005-07-22 2007-01-26 Nextamp Sa Procede et dispositif de tatouage d'horodates, procede et dispositif de decodage d'horodates, applications et produits programmes d'ordinateur correspondants

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3526015A1 (de) * 1985-07-20 1987-01-22 Philips Patentverwaltung Verfahren zum bestimmen der raeumlichen verteilung der streuquerschnitte fuer elastisch gestreute roentgenstrahlung und anordnung zur durchfuehrung des verfahrens
US5004746A (en) * 1987-09-29 1991-04-02 Merrell Dow Pharmaceuticals Inc. Anti-retroviral castanospermine esters
US4999146A (en) * 1990-02-12 1991-03-12 Thermax Wire Corp. Process for manufacture of low density polytetrofluoroethylene insulated cable
NZ241099A (en) * 1991-01-02 1994-08-26 Merrell Dow Pharma Difluorostatone analogues and derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
HUT72493A (en) 1996-05-28
NO953272L (no) 1995-08-21
ZA941036B (en) 1994-08-25
KR960700743A (ko) 1996-02-24
CA2155129C (en) 1999-04-13
IL108696A (en) 1999-06-20
KR100293299B1 (ko) 2001-09-17
AU679497B2 (en) 1997-07-03
IL108696A0 (en) 1994-05-30
NO307738B1 (no) 2000-05-22
HU9502451D0 (en) 1995-10-30
AU6091894A (en) 1994-09-14
EP0684836A1 (en) 1995-12-06
CA2155129A1 (en) 1994-09-01
NO953272D0 (no) 1995-08-21
CN1118142A (zh) 1996-03-06
WO1994019008A1 (en) 1994-09-01
JPH08509469A (ja) 1996-10-08
NZ261740A (en) 1996-10-28
MXPA94001311A (es) 2003-11-13

Similar Documents

Publication Publication Date Title
IL108075A0 (en) Enzyme inhibitors
IL90218A0 (en) Retroviral protease inhibitors
AU627937B2 (en) Inhibitors of retroviral proteases
ZA915269B (en) Retroviral protease inhibitors
IL102534A0 (en) Retroviral protease inhibitors
PH30121A (en) Retroviral protease inhibitors
GB9314822D0 (en) Determination of position
ZA915271B (en) Inhibitors of retroviral proteases
ZA899558B (en) Retroviral protease inhibitors
AU6723294A (en) Use of simmondsine
EP0713496A4 (en) THROMBINE INHIBITORS TARGETED ON FIBRIN
GB9214720D0 (en) Enzyme inhibitors
AU3735793A (en) Retroviral protease inhibitors
ZA941036B (en) Combinations of retroviral inhibitors
ZA939480B (en) Enzyme inhibitor
GB9311043D0 (en) Inhibitors of nef-cd4 binding
IL105450A0 (en) Hydroxy-carbamate retroviral protease inhibitors
ZA949525B (en) Enzyme inhibitors
ZA924089B (en) Novel thrombin inhibitors
ZA907727B (en) Inhibitors of retroviral proteases
ZA9010068B (en) Inhibitors of retroviral proteases
ZA944932B (en) Use of phenalkylamines
PL55382Y1 (en) Set of symmetrisers
GB9208596D0 (en) Inhibitors of thrombin
GB9309338D0 (en) Coating of steels